News

Cephalon, a biopharmaceutical company, has announced that its wholly-owned subsidiary, Cephalon International Holdings, intends to make a takeover offer for Australia-based biotechnology company Arana Therapeutics. Under its bid,

Pluristem Therapeutics has announced that the FDA has cleared the company’s investigational new drug application to initiate a Phase I clinical trial for the treatment of critical limb

Power Medical Interventions, a developer of surgical instruments, has received a $2.5m payment from Intuitive Surgical, a developer of minimally invasive surgery systems. The payment to Power Medical

Fourth quarter revenues declined from third quarter levels due to delayed recognition of contract revenue, exchange rate impacts and seasonality. Total revenues for the fourth quarter of 2008

Winner Medical Group, a manufacturer of medical and wound care products, has announced that the European Patent Office has decided to grant the patent for producing PurCotton products

Net loss applicable to common shares for the year ended December 31, 2008 was $42.3 million, or $2.47 per basic and diluted share, compared to a net loss

Cell Genesys, a biotechnology company, has announced positive results from further analyses of Vital-1, the company’s recently terminated Phase III clinical trial which compared Gvax immunotherapy for prostate

Oncologix Tech, a developer of medical device for brachytherapy, has signed an agreement with Institut fur Umwelttechnologien, a German company under which the company is licensing its technical

Millennium Pharmaceuticals, a wholly-owned subsidiary of Takeda Pharmaceutical Company, has initiated two Phase II clinical trials of MLN8237. The first trial will examine the molecule in adult patients